Diagnosis

Alcoholic liver disease

Liver injury associated with long-term heavy intake of ethanol. Alcohol-related liver manifestations:

  1. Fatty liver disease

  2. Alcoholic hepatitis

  3. Liver fibrosis

  4. Cirrhosis

Also known as: Alcoholic cirrhosis, Alcoholic fatty liver, Alcoholic hepatitis, Alcoholic steatosis

Etiology

Pathophysiology

The precise mechanism of alcoholic liver disease remains in dispute: [kfz]

The relative risk of cirrhosis rises significantly for alcohol intake above 60 g/day for men and 20 g/day for women over a decade [dfu][9oc][dir]. 1 beverage = 14 grams of alcohol. With continued heavy alcohol consumption, the alcoholic liver disease progress from fatty liver (steatosis) --> hepatitis --> cirrhosis. [nd8]

  1. Alcoholic Fatty Liver (steatosis):

    • ~20% of alcoholics and heavy drinkers

    • Usually no clinical symptoms except for hepatomegaly

    • Fatty liver can be reversed if alcohol consumption is stopped

  2. Alcoholic Hepatitis

    • Liver biopsy indicates inflammatory changes, liver degeneration, fibrosis

    • Clinical signs: hepatomegaly, nausea, vomiting, abdominal pain, fever, jaundice

    • If heavy drinking continues, ~40% of cases of alcoholic hepatitis --> cirrhosis

  3. Alcoholic Cirrhosis

    • ~10-15% with alcoholism develop cirrhosis

    • The most serious form of ALD

    • Scar tissue replaces normal liver tissue, disrupting blood flow through the liver and preventing it from working properly

    • Clinical signs: palmar erythema, finger contractures, white nails, nails clubbing, hepatomegaly, inflammation, steatosis, jaundice, ascites, or gastrointestinal bleeding

    • The survival rate is only 60 percent for those who stop drinking and 35 percent for those who do not

Epidemiology

Incidence per 100.000 [dir][ton][dsy][yno][d79][ays][ofq][nd8]

Epidemiology chart for Incidence

Symptoms & findings

Symptoms

Anorexia, Asterixis, Confusion, Dark urine, Delirium, Edema, Fatigue, Fever, Hematemesis, Hematochezia, Hepatomegaly, Lethargy, Malaise, Melena, Muscle atrophy, Nausea, Spider nevus, Splenomegaly, Tachycardia, Tachypnea, Tremor, Weight loss

Clinical findings

Alkalosis, Ascites, Decreased Albumin, Elevated ALAT, Elevated ALP, Elevated ASAT, Elevated Bilirubin, Elevated GGT, Elevated PT-INR, Gynecomastia, Jaundice, Leukocytosis, Thrombocytopenia

Anamneses

Alcohol

Localized findings

Pain
Radiates
RUQ (Right Upper Quadrant)
Onset
Subacute (hours)Gradual (days)
Pattern
Constant
Severity
Mild (1-3)Moderate (4-7)
Swelling
Radiates
Abdomen
Onset
Gradual (days)

Approach

Treatment

  1. Alcohol abstinence is the single most important determinant of long-term patient survival

  2. Treatment of complications: [kfz]

    • Nutritional supplementation: vitamins and minerals, including folate and thiamine

    • Variceal hemorrhage: Protection of the airway, resuscitation, interventional endoscopy (sclerotherapy or banding ligation), infusion of portal antihypertensive (somatostatin), balloon tamponade, transjugular intrahepatic portosystemic shunt, or an emergency portal-caval shunt

    • Hepatic encephalopathy: Lactulose or nonabsorbable antibiotics, ammonium, intracranial pressure monitoring

    • Ascites: Salt restriction, diuretics, paracentesis, and intravenous albumin supplementation

    • Spontaneous bacterial peritonitis: diagnostic paracentesis --> broad-spectrum antibiotic therapy (cephalosporin)

    • Alcoholic hepatitis: Corticosteroid (prednisolone 40 mg/d) is recommended as the first-line treatment of severe AH patients

    • Cirrhosis: Liver transplantation (required a minimum 6-month abstinence)

Differential diagnoses

Autoimmune hepatitis, Chronic pancreatitis, Drug-induced liver injury, Hemochromatosis, Nonalcoholic fatty liver disease, Viral hepatitis


References

[1] https://emedicine.medscape.com/article/170539

[2] Testino G, Leone S, Fagoonee S, Pellicano R. Alcoholic liver fibrosis: detection and treatment. Minerva Med. 2018 Dec;109(6):457-471.

[3] Bellentani S, Tiribelli C. The spectrum of liver disease in the general population: lesson from the Dionysos study. J Hepatol. 2001 Oct;35(4):531-7.

[4] Becker U, Deis A, Sørensen TI, Grønbaek M, Borch-Johnsen K, Müller CF, Schnohr P, Jensen G. Prediction of risk of liver disease by alcohol intake, sex, and age: a prospective population study. Hepatology. 1996 May;23(5):1025-9.

[5] Mann RE, Smart RG, Govoni R. The epidemiology of alcoholic liver disease. Alcohol Res Health. 2003;27(3):209-19.

[6] Rattanamongkolgul S, Wongjitrat C, Puapankitcharoen P. Prevalence of cirrhosis registered in Nakhon Nayok, Thailand. J Med Assoc Thai. 2010 Feb;93 Suppl 2:S87-91.

[7] Kim, H.I., Park, S.Y. & Shin, H.P. Incidence and management patterns of alcohol-related liver disease in Korea: a nationwide standard cohort study. Sci Rep 11, 6648 (2021).

[8] Han S, Yang Z, Zhang T, Ma J, Chandler K, Liangpunsakul S. Epidemiology of Alcohol-Associated Liver Disease. Clin Liver Dis. 2021 Aug;25(3):483-492.

[9] Huang, D.Q., Mathurin, P., Cortez-Pinto, H. et al. Global epidemiology of alcohol-associated cirrhosis and HCC: trends, projections and risk factors. Nat Rev Gastroenterol Hepatol 20, 37–49 (2023).

[10] Fleming KM, Aithal GP, Solaymani-Dodaran M, Card TR, West J. Incidence and prevalence of cirrhosis in the United Kingdom, 1992-2001: a general population-based study. J Hepatol. 2008 Nov;49(5):732-8.

[11] Wu, M., Qin, S., Tan, C. et al. Estimated projection of incidence and mortality of alcohol-related liver disease in China from 2022 to 2040: a modeling study. BMC Med 21, 277 (2023).

Scroll to top